HPV vaccine production delayed due to COVID focus: SII
The Serum Institute of India (SII) will start supplying the HPV vaccine to the Indian government in early 2023
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Serum Institute of India
SII stopped Covishield production in Decemeber 2021: Poonawalla
Speaking to reporters on the sidelines of the annual general meeting of the Developing Countries Vaccine Manufacturers Network…
DCGI allows Serum Institute to export malaria vaccine to UK: Report
Currently, only one vaccine against malaria is available globally and GSK is the manufacturer of that
Nigeria to produce vaccines locally with SII
Africa's most populous country imports all of its vaccines, including those used to prevent polio, measles and tuberculosis, but…
Phase-III trials of Novavax’s vaccine show high levels of protection against infection:…
SII and Novavax are the key partners in the development and manufacturing of the Novavax vaccine, marketed by Novavax as Nuvaxovid…
US delegation visits SII
The delegates noted the critical role played by the US-India cooperation in addressing the COVID-19 pandemic and other global…
Centre plans to include SII’s qHPV vaccine against cervical cancer in national immunization…
Prime Minister Narendra Modi is likely to make an announcement on 15th August, according to sources
SII tells Centre it can supply one crore doses of qHPV vaccine against cervical cancer by December
The government advisory panel NTAGI recently is learnt to have also approved the qHPV after reviewing the clinical trial data of…
Health ministry seeks five crore free Covishield doses from GAVI under COVAX
Amid rising cases of coronavirus in the country, the government started providing precaution doses free of cost to those aged 18…
US secures 3.2 million doses of COVID-19 vaccine by Novavax
The US Department of Health and Human Services (HHS), in collaboration with the Department of Defence (DOD), announced that it has…